Clinical Trial Update: Valsartan in Cardiovascular Disease With Renal Dysfunction (The V-CARD) Study [Phase 4]

View source ↗

Summary

Phase 4 trial of valsartan for hypertension with renal dysfunction (V-CARD) has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hypertension

Drugs mentioned

• VALSARTAN (Valsartan)

Snippet

Sponsor: Kumamoto University | Conditions: Hypertension | Phase 4 | Status: TERMINATED